BFSG »

Inozyme Pharma shares owned by BFSG

Quarter-by-quarter ownership of Inozyme Pharma (INZY) shares owned by BFSG from 13F filings

Historical chart of BFSG investment in Inozyme Pharma

Tip: Access up to 7 years of quarterly data

All positions including Inozyme Pharma held by BFSG consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Inozyme Pharma by BFSG

Quarter filed Position value Share count Share price at filing
2024-09-30 $2.6k 500 5.23
2024-06-30 $2.2k 500 4.46
2024-03-31 $3.8k 500 7.66

More positions owned by BFSG

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Microsoft Corporation (MSFT)
Vanguard Index Fds Total Stk Mkt (VTI)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Ishares Gold Tr Ishares New (IAU)
American Centy Etf Tr Us Sml Cp Valu (AVUV)
Vanguard Bd Index Fds Total Bnd Mrkt (BND)
Dimensional Etf Trust Emerging Mkts Co (DFEM)
Church & Dwight (CHD)
Raytheon Technologies Corp (RTX)
Vanguard World Energy Etf (VDE)
CSX Corporation (CSX)
Etfs Gold Tr Physcl Gold Shs (SGOL)
Novo-nordisk A S Adr (NVO)

View all positions for BFSG

Top funds holding Inozyme Pharma

Pivotal bioVenture Partners Investment Advisor
Sofinnova Ventures
Eventide Asset Management
Rock Springs Capital Management
BlackRock
BlackRock
Samlyn Capital
Affinity Asset Advisors
Vanguard Group
NEA Management Company
Samsara BioCapital
Sphera Funds Management
Geode Capital Management
Saturn V Capital Management
Blue Owl Capital Holdings

View all funds holding Inozyme Pharma